European
September 12, 2023 blogger analysis, analytics, Business, cannabis, CBD, compliance, consumer, Cultivation, Epidiolex, Europe, European, extraction, Federal, government, Growing, industry, International, lab, laboratories, laboratory, labs, Law, Legal, legalization, Legalize, legislation, license, marijuana, market, Medical, Medicial Marijuana, Medicine, product, quality, regulation, Regulations, regulatory, Retail, safety, state, Stop Smoking Marijuana, Stop Smoking Pot, test, Testing, UK, Union, United Kingdom, united states, weed, withdrawal
This is the final piece of a four-part series discussing European cannabis regulations. Click here for Part One, here for Part Two and here for Part Three. Part Four wraps up the series below. Where is the future of CBD heading? A review of these various jurisdictions, the EU, the UK, and the USA, makes it clear that […]
analysis, analytics, Business, cannabis, CBD, compliance, consumer, Cultivation, Epidiolex, Europe, European, extraction, Federal, government, Growing, industry, International, lab, laboratories, laboratory, labs, Law, legal, legalization, Legalize, legislation, license, marijuana, market, Medical, Medicine, product, quality, regulation, Regulations, regulatory, Retail, safety, state, test, Testing, UK, Union, United Kingdom, united states
September 6, 2023 blogger analysis, Business, cannabis, CBD, compliance, consumer, Cultivation, Epidiolex, EU, European, extraction, farm bill, FDA, Federal, FSA, government, Growing, GW Pharma, industry, International, laboratories, laboratory, Law, Legal, legalization, Legalize, legislation, license, marijuana, market, Medical, Medicial Marijuana, Medicine, product, quality, regulation, Regulations, regulatory, Retail, safety, state, Stop Smoking Marijuana, Stop Smoking Pot, test, Testing, THC, UK, Union, United Kingdom, weed, withdrawal
This is Part Three of a four-part series discussing European cannabis regulations. Click here for Part One and here for Part Two. Part Three dives into dosage, approvals and more. Stay tuned for the final Part Four, coming next week. But does CBD harm the liver? Here, it is important that we compare apples to apples. […]
analysis, Business, cannabis, CBD, compliance, consumer, Cultivation, Epidiolex, EU, European, extraction, farm bill, FDA, Federal, FSA, government, Growing, GW Pharma, industry, International, laboratories, laboratory, Law, legal, legalization, Legalize, legislation, license, marijuana, market, Medical, Medicine, product, quality, regulation, Regulations, regulatory, Retail, safety, state, test, Testing, THC, UK, Union, United Kingdom
August 28, 2023 blogger american, analysis, analytics, authority, British, Business, cannabis, CBD, compliance, consumer, Cultivation, dispensary, EFSA, Epidiolex, Europe, European, export, extraction, FDA, Federal, food, government, Growing, import, industry, International, lab, laboratories, laboratory, Law, Legal, legalization, Legalize, legislation, license, marijuana, market, Medical, Medicial Marijuana, Medicine, product, quality, regulation, Regulations, regulatory, safety, state, Stop Smoking Marijuana, Stop Smoking Pot, THC, UK, Union, United Kingdom, united states, weed, withdrawal
This is Part Two of a four-part series discussing European cannabis regulations. Click here for Part One. Part Two analyzes the differences between the UK, the EU and the US. Part Three, coming next week, dives into dosage, approvals and more. Stay tuned for more. EU Regulatory Environment We Europeans look with envy at the […]
american, analysis, analytics, authority, British, Business, cannabis, CBD, compliance, consumer, Cultivation, dispensary, EFSA, Epidiolex, Europe, European, export, extraction, FDA, Federal, food, government, Growing, import, industry, International, lab, laboratories, laboratory, Law, legal, legalization, Legalize, legislation, license, marijuana, market, Medical, Medicine, product, quality, regulation, Regulations, regulatory, safety, state, THC, UK, Union, United Kingdom, united states
August 21, 2023 blogger analysis, analytics, Business, cannabis, CBD, consumer, dispensary, Europe, European, extraction, Federal, food, government, Growing, industry, International, laboratory, labs, Law, Legal, legalization, Legalize, legislation, license, marijuana, market, Medical, Medicial Marijuana, Medicine, novel, product, quality, Recreational, regulation, Regulations, regulatory, Shelley Stark, Stop Smoking Marijuana, Stop Smoking Pot, THC, UK, Union, United Kingdom, weed, withdrawal
This is Part One of a four-part series discussing European cannabis regulations. Part One serves as an introduction. Part Two, coming next week, will analyze the differences between the UK, the EU and the US. Stay tuned for more. As I walk through any European cannabis expo – events like Cultiva Hanfexpo, Cannafest Prague or […]
analysis, analytics, Business, cannabis, CBD, consumer, dispensary, Europe, European, extraction, Federal, food, government, Growing, industry, International, laboratory, labs, Law, legal, legalization, Legalize, legislation, license, marijuana, market, Medical, Medicine, novel, product, quality, Recreational, regulation, Regulations, regulatory, Shelley Stark, THC, UK, Union, United Kingdom
July 25, 2023 blogger analysis, analytics, Business, cannabis, CBD, compliance, consumer, Cultivation, dispensary, Europe, European, Federal, German, Germany, government, Growing, industry, International, Legal, legalization, Legalize, legislation, license, marijuana, Medical, Medicial Marijuana, Medicine, Recreational, Regulations, regulatory, Stop Smoking Marijuana, Stop Smoking Pot, weed, withdrawal
Following the German cannabis reform movement is like watching a snowboard jump competition. We launch into the big jump with lofty promises, only to face the difficulty of gaining meaningful, immediate momentum at the bottom of the halfpipe. Nevertheless, we persevere through smaller political moves that set us up for more advanced regulatory jumps, all […]
analysis, analytics, Business, cannabis, CBD, compliance, consumer, Cultivation, dispensary, Europe, European, Federal, German, Germany, government, Growing, industry, International, legal, legalization, Legalize, legislation, license, marijuana, Medical, Medicine, Recreational, Regulations, regulatory
January 5, 2023 blogger analysis, analytics, Bloomwell, Business, Business Analysis, C-suite, Canada, canadian, cannabis, capital, capitalist, CBD, compliance, consumer, Cultivation, dispensary, EU, Europe, European, export, extraction, Federal, finance, financing, German, Germany, government, Growing, import, income, industry, International, invest, Investing, investment, Law, leadership, Legal, legalization, Legalize, legislation, leverage, license, Luxembourg, Malta, marijuana, market, Medical, Medicial Marijuana, opportunities, product, Product Development, quality, Recreational, regulation, Regulations, regulatory, Retail, Soapbox, state, statement, Stop Smoking Marijuana, Stop Smoking Pot, Tilray, VC, venture, weed, withdrawal
For U.S. venture capitalists (VCs), the burgeoning European cannabis market provides opportunities to break into the industry on the heels of adult-use legalization. Germany has set its sights on implementing a recreational market by 2024, and the country, along with several other European Union (EU) countries–Malta and Luxembourg–came together in September 2022 to draft a […]
analysis, analytics, Bloomwell, Business, Business Analysis, C-suite, Canada, canadian, cannabis, capital, capitalist, CBD, compliance, consumer, Cultivation, dispensary, EU, Europe, European, export, extraction, Federal, finance, financing, German, Germany, government, Growing, import, income, industry, International, invest, Investing, investment, Law, leadership, legal, legalization, Legalize, legislation, leverage, license, Luxembourg, Malta, marijuana, market, Medical, opportunities, product, Product Development, quality, Recreational, regulation, Regulations, regulatory, Retail, Soapbox, state, statement, Tilray, VC, venture